The global fertility market size accounted for USD 39.27 billion in 2025 and is forecasted to hit around USD 85.53 billion by 2034, representing a CAGR of 9.03% from 2025 to 2034. The growing awareness of fertility treatments across developed and emerging regions.
Fertility Market
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Fertility Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Fertility Market, by Offering
8.1.1. Assisted Reproductive Technology
8.1.1.1. Market Revenue and Forecast
8.1.2. Fertility Drugs
8.1.2.1. Market Revenue and Forecast
9.1. Fertility Market, by End user
9.1.1. Fertility Clinics
9.1.1.1. Market Revenue and Forecast
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast
9.1.3. Clinical Research Institutes
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Offering
10.1.2. Market Revenue and Forecast, by End user
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Offering
10.1.3.2. Market Revenue and Forecast, by End user
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Offering
10.1.4.2. Market Revenue and Forecast, by End user
10.2. Europe
10.2.1. Market Revenue and Forecast, by Offering
10.2.2. Market Revenue and Forecast, by End user
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Offering
10.2.3.2. Market Revenue and Forecast, by End user
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Offering
10.2.4.2. Market Revenue and Forecast, by End user
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Offering
10.2.5.2. Market Revenue and Forecast, by End user
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Offering
10.2.6.2. Market Revenue and Forecast, by End user
10.3. APAC
10.3.1. Market Revenue and Forecast, by Offering
10.3.2. Market Revenue and Forecast, by End user
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Offering
10.3.3.2. Market Revenue and Forecast, by End user
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Offering
10.3.4.2. Market Revenue and Forecast, by End user
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Offering
10.3.5.2. Market Revenue and Forecast, by End user
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Offering
10.3.6.2. Market Revenue and Forecast, by End user
10.4. MEA
10.4.1. Market Revenue and Forecast, by Offering
10.4.2. Market Revenue and Forecast, by End user
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Offering
10.4.3.2. Market Revenue and Forecast, by End user
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Offering
10.4.4.2. Market Revenue and Forecast, by End user
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Offering
10.4.5.2. Market Revenue and Forecast, by End user
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Offering
10.4.6.2. Market Revenue and Forecast, by End user
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Offering
10.5.2. Market Revenue and Forecast, by End user
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Offering
10.5.3.2. Market Revenue and Forecast, by End user
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Offering
10.5.4.2. Market Revenue and Forecast, by End user
11.1. Boston IVF Fertility Clinic
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. INVO Bioscience
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. San Diego Fertility Center
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Celmatix
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. FUJIFILM IRVINE SCIENTIFIC
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Carolinas Fertility Institute
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Progyny Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Cook Medical
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. LifeGlobal Group (Cooper Surgical)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description